1. Home
  2. WAL vs RGEN Comparison

WAL vs RGEN Comparison

Compare WAL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Alliance Bancorporation (DE)

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$85.61

Market Cap

8.7B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$165.99

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAL
RGEN
Founded
1994
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
8.2B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
WAL
RGEN
Price
$85.61
$165.99
Analyst Decision
Strong Buy
Buy
Analyst Count
14
10
Target Price
$99.64
$174.90
AVG Volume (30 Days)
855.4K
618.1K
Earning Date
01-26-2026
10-28-2025
Dividend Yield
1.76%
N/A
EPS Growth
24.99
N/A
EPS
8.09
0.03
Revenue
$3,189,400,000.00
$707,890,000.00
Revenue This Year
$16.21
$17.84
Revenue Next Year
$9.07
$12.44
P/E Ratio
$10.70
$6,531.87
Revenue Growth
9.57
11.74
52 Week Low
$57.05
$102.97
52 Week High
$94.40
$182.52

Technical Indicators

Market Signals
Indicator
WAL
RGEN
Relative Strength Index (RSI) 53.98 58.15
Support Level $85.14 $156.01
Resistance Level $88.09 $167.74
Average True Range (ATR) 2.01 4.44
MACD -0.23 0.13
Stochastic Oscillator 42.78 85.17

Price Performance

Historical Comparison
WAL
RGEN

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: